Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Two-herb traditional Chinese medicine proves beneficial for diabetic foot ulcers

Jan. 28, 2014

Sosei transfers Japanese marketing authorization for emergency contraceptive to ASKA

Jan. 28, 2014

Korean researchers present new fusion proteins for diabetes

Jan. 28, 2014

Novel endothelial lipase inhibitors synthesized by Bristol-Myers Squibb

Jan. 28, 2014

EMA committee recommends approval of Finox Biotech's biosimilar FSH

Jan. 27, 2014

Japanese researchers divulge new sst2 receptor agonists

Jan. 27, 2014

GSK receives positive CHMP opinion for albiglutide in type 2 diabetes

Jan. 27, 2014

Novel PCSK9 inhibitors designed by Cadila Healthcare for dyslipidemia

Jan. 24, 2014

Amgen reports topline data from phase III GAUSS-2 trial

Jan. 24, 2014

Companies sign agreements for darbepoetin alfa biosimilar in Japan

Jan. 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...